Member Info for StoneyD

This share is a con from start to finish, from an ex loser of £3k.

DOR and see http://www.futuramedical.com/archive/prelims230317.pdf?=v2

That would appear to be a reasonable assumption on the simple basis of having three separate pain relief doses up for sale instead of one or two, and therefore covers a wider sales spectrum. At present they only have Thornton and Ross as a licence holder for the UK and must now be negotiating with other potential holders, which is why Ken James was recruited and why they have upped the commercial potential accordingly The other point I have raised is that sales for CSD500 will also support the additional costs involved. All good stuff IMO. Cheers

Chariot: I would like to put on record that I have e mailed James Barder and asked if the European manufacturer of CSD500 had been rejected and his reply, received within minutes, was "absolutely not"

It is designed so that it doesn't reflect on the sp, Clearly, this strategy in the case of FUM is to maintain the sp, interpret that how you will, but I dont think they are protecting themselves against a drop, rather the reverse given the potential and the number of license holders. Have a look at PLE in contrast,.with just one license holder that of Recordati.and see which way that sp is going (HK 0575 Regent Pacific). Cheers

What is a 'Block Trade' A block trade, also known as a block order, is an order or trade submitted for the sale or purchase of a large quantity of securities. A block trade involves a significantly large number of equities or bonds being traded at an arranged price between two parties, sometimes outside of the open markets, to lessen the impact on the security price. In general, 10,000 shares of stock, not including penny stocks, or $200,000 worth of bonds are considered a block trade. BREAKING DOWN 'Block Trade' Due to the size of block trades, both on the debt and equities markets, individual investors rarely, if ever, make block trades. In practice, these trades typically occur when large hedge funds and institutional investors buy and sell large sums of bonds and shares in block trades via investment banks and other intermediaries. If a block trade is conducted on the open market, traders must be careful with the trade, seeing as it causes large fluctuations in volume and can impact the market value of the shares or bonds being purchased. Therefore, block trades are usually conducted through an intermediary, rather than the hedge fund or investment bank purchasing the securities normally, as they would for smaller amounts. Read more: Block Trade http://www.investopedia.com/terms/b/blocktrade.asp#ixzz4howx3kY7 Follow us: Investopedia on Facebook

Mathsman: That was then and this is now, 2017 is the year it starts to move on sales, it takes at least five years to get through Phase 1-3 clinical trials and qualifications, plus the shelf life problems, but thats now all history

Dont LCT Global have to complete Phase 111a clinical trials after successful conclusion of Phase 11a and b before they can submit an NDA to market the drug in the EU or WW? Just asking.

Sorry delete a)

a)Before MED2002 and Painkillers are ready for market X because Dermasys is too attractive to large Pharma. b)around the time MED2002 and Painkillers are ready for market X because phase 111 tests on products will have completed c)after MED2002 and Painkillers are available on the market d) FUM will not be of interest to large Pharma. e) Any other (stated) option

Chart looks very good with a breakout in progress through the upper Bollinger band, could be 60p by end of week

and about time too!!

I cant believe there is so little trading in this share given the potentialities on a relatively short term basis.

GCCRa: Well I am waiting and I am invested, and I believe this is going to move up once the sales can start for CSD500 which will be mid June onwards.

Daringinvestor: Those calcs dont include the licence up front payments ??

GCCRa: No I was right and you are wrong, you misunderstood me, I have fully researched this share and know it's a potential sleeping blockbuster, and it's sleeping still, with lots of news coming up this year, but very few are buying and it's a quiet BB. The market has yet to take it up, but it will when CDS500 takes off mid year and sales start coming in. so at the mo there aint much going on now and its very quiet, but not for much longer :-)) Cheers

Not much doing here then, patience is needed.

I agree with you. The EU Milsing manufacturer has not yet been approved and that would explain the NL situation.

Hawky: I recon you might be a wee bit pessimistic there, how about £4.15 minimum?? :-))

Hawky: So what do you think the Sp will be over the next two years then? Cheers